Entries of Ebert, M. P. on the publication server

Itzel, T., Spang, Rainer, Maass, T., Munker, S., Roessler, S. , Ebert, M. P., Schlitt, Hans J., Herr, Wolfgang, Evert, Matthias and Teufel, A. (2019) Random gene sets in predicting survival of patients with hepatocellular carcinoma. J. Mol. Med.. Fulltext not available.

Feng, T., Dzieran, J., Yuan, X., Dropmann, A., Maass, T., Teufel, A., Marhenke, S., Gaiser, T., Rückert, F., Kleiter, I., Kanzler, S., Ebert, M. P., Vogel, A., ten Dijke, P., Dooley, S. and Meindl-Beinker, N. M. (2017) Hepatocyte-specific Smad7 deletion accelerates DEN-induced HCC via activation of STAT3 signaling in mice. Oncogenesis 6 (1), e294-e294. Fulltext not available.

Fensterer, H., Schade-Brittinger, C., Mueller, H., Schupfner, B., Fass, J., Lindig, U., Settmacher, U., Ebert, M. P., Kornmann, M., Hofheinz, R., Endlicher, E., Brendel, C., Barth, P. J., Bartsch, D. K. and Gress, T. M. (2011) Multicenter phase II trial to investigate safety and efficacy of an adjuvant therapy with gemcitabine and cetuximab in patients with R0 or R1 resected pancreatic cancer. Journal of Clinical Oncology 29 (15_sup), p. 4039. Fulltext not available.